EYES - Second Sight Medical Products Inc Stock Price, Fair Value and News

$1.290.00 (0.00%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

EYES Price Action

Last 7 days

4.0%

Last 30 days

4.0%

Last 90 days

2.3%

Trailing 12 Months

37.9%

EYES RSI Chart

EYES Valuation

Market Cap

76.4M

Price/Earnings (Trailing)

-3.26

Price/Sales (Trailing)

173.34

Price/Free Cashflow

-3.93

EYES Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

EYES Fundamentals

EYES Revenue

Revenue (TTM)

475.0K

EYES Earnings

Earnings (TTM)

-23.5M

Earnings Growth (Yr)

10.93%

Earnings Growth (Qtr)

-12.79%

EYES Profitability

Operating Margin

-877.98%

Return on Equity

-127.98%

Return on Assets

-54.7%

Free Cashflow Yield

-25.46%

EYES Investor Care

Shares Dilution (1Y)

16.09%

Diluted EPS (TTM)

-0.47

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	0	0	0	0
2022	512.5K	0	0	475.0K
2021	149.5K	283.0K	416.5K	550.0K
2020	2.3M	1.1M	0	16.0K
2019	7.0M	6.4M	4.6M	3.4M
2018	7.9M	7.6M	8.2M	6.9M
2017	3.9M	5.1M	5.6M	8.0M
2016	8.3M	6.7M	5.6M	4.0M
2015	4.4M	6.5M	8.1M	8.9M
2014	2.0M	2.5M	2.9M	3.4M
2013	0	0	0	1.6M

Get all data in R, Python etc through our Historical Stock Data APIs

About Second Sight Medical Products Inc

WEBSITE	secondsight.com

Second Sight Medical Products Inc Frequently Asked Questions

What is the ticker symbol for Second Sight Medical Products Inc? What does EYES stand for in stocks?

EYES is the stock ticker symbol of Second Sight Medical Products Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Second Sight Medical Products Inc (EYES)?

As of Tue Nov 19 2024, market cap of Second Sight Medical Products Inc is 76.41 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of EYES stock?

You can check EYES's fair value in chart for subscribers.

Is Second Sight Medical Products Inc a good stock to buy?

The fair value guage provides a quick view whether EYES is over valued or under valued. Whether Second Sight Medical Products Inc is cheap or expensive depends on the assumptions which impact Second Sight Medical Products Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EYES.

What is Second Sight Medical Products Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Nov 19 2024, EYES's PE ratio (Price to Earnings) is -3.26 and Price to Sales (PS) ratio is 173.34. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EYES PE ratio will change depending on the future growth rate expectations of investors.